# Vertical Integration **Vertical integration** is the strategy of combining multiple stages of a supply chain — from production to distribution to retail — under a single corporate roof. While the concept applies across industries (oil companies owning refineries and gas stations, tech companies owning hardware and software), the most politically consequential application in the KB is in American healthcare, where the merger of insurers, providers, [[Pharmacy Benefit Managers]], and pharmacies into unified conglomerates has reshaped how care is delivered, priced, and denied. ## The General Concept In economic theory, vertical integration can create genuine efficiencies: reduced transaction costs, better coordination, elimination of double marginalization (each middleman adding its own markup). But it also creates market power. When one company controls multiple links in the chain, it can steer customers to its own downstream services, foreclose competitors' access to essential inputs, and obscure internal transfer prices — making it nearly impossible for regulators, patients, or employers to determine where profit is being extracted. The [[Antitrust]] tradition distinguishes vertical integration (combining different stages of a chain) from horizontal consolidation (buying competitors at the same stage). Historically, American [[Antitrust]] enforcement under the [[Sherman Antitrust Act]] focused more aggressively on horizontal mergers; vertical integration received lighter scrutiny on the theory that it merely shifted profits within a supply chain rather than eliminating competition. That theory is now under sustained challenge, particularly in healthcare. ## The Healthcare Exemplars ### UnitedHealth Group / Optum [[UnitedHealth Group]] is the paradigm case. It operates UnitedHealthcare, the nation's largest health insurer (~50 million covered lives), alongside Optum, a sprawling health-services conglomerate that includes OptumHealth (one of the nation's largest employer of physicians, with ~90,000 doctors), OptumRx (one of the three dominant [[Pharmacy Benefit Managers]]), and OptumInsight (a health-data analytics platform). The company's 2025 revenue exceeded $400 billion, making it the largest healthcare company in the world by revenue. The structural concern is what critics call the "flywheel": UnitedHealthcare steers patients to Optum providers, Optum providers generate data that feeds OptumInsight, OptumInsight's analytics inform [[Prior Authorization]] and [[Claim Denial]] decisions that benefit UnitedHealthcare's medical-loss ratio, and OptumRx controls the pharmacy benefit for the same patient population. At every node, the company captures margin — and because the transactions occur within a single corporate entity, the transfer prices are opaque. ### CVS Health / Aetna / Caremark [[CVS Health]]'s 2018 acquisition of Aetna created a second vertical giant: a company that operates the nation's largest pharmacy chain (~9,000 retail locations), a major health insurer (Aetna, ~25 million covered lives), one of the three dominant [[Pharmacy Benefit Managers]] (CVS Caremark), and a growing network of MinuteClinic and HealthHUB primary-care locations. The combination means CVS can adjudicate the pharmacy benefit, fill the prescription, and provide the clinical care — all within one company. ### Cigna / Evernorth [[Cigna]]'s Evernorth division houses Express Scripts, another of the three dominant [[Pharmacy Benefit Managers]], alongside specialty pharmacy, benefits management, and clinical services. The structure mirrors the UnitedHealth model at smaller scale. ## The DOJ Offensive The [[Department of Justice]] opened a civil antitrust investigation into [[UnitedHealth Group]] in 2024, focused on whether Optum's aggressive acquisition of physician practices, urgent care centers, and data firms has stifled competition, limited patient choice, and inflated costs. The investigation escalated to active litigation in late 2025, with the DOJ framing it as a fundamental challenge to the vertical-integration strategy that has defined the industry for a decade. The probe represents a notable shift: under [[Lina Khan]]'s [[FTC]] and the DOJ's antitrust division, the Biden-era enforcers signaled a more skeptical posture toward vertical mergers broadly, treating them as presumptively problematic rather than presumptively efficient. The Trump administration's DOJ has continued the investigation — a bipartisan consensus on healthcare market power that is rare in the current political environment. Congressional action has paralleled the enforcement: bipartisan Senate bills introduced in 2025 would prohibit insurers from owning [[Pharmacy Benefit Managers]], directly targeting the vertical structures that define the industry's three largest players. ## Why It Matters Beyond Healthcare Vertical integration is not unique to healthcare. The [[Big Tech]] ecosystem exhibits similar dynamics: [[Google]] owns the search engine, the ad exchange, the browser, the mobile OS, and the video platform — a vertical stack that the DOJ's separate [[Antitrust]] case against [[Alphabet]] directly challenges. [[Amazon]] combines the marketplace, the logistics network, the cloud infrastructure, and a growing private-label business. The healthcare cases are important partly because they establish precedents that will influence how regulators approach vertical power in technology, media, and finance. ## KB Relevance Vertical integration is the structural concept that explains why the [[Healthcare Industry Ecosystem]] pages — [[UnitedHealth Group]], [[CVS Health]], [[Cigna]], [[Pharmacy Benefit Managers]], [[Drug Pricing]], [[Prior Authorization]], [[Claim Denial]] — fit together as a system rather than as isolated companies. It also connects healthcare market power to the broader [[Antitrust]] revival documented across the vault, from the [[Lina Khan]] [[FTC]] to the [[Google]] and [[Amazon]] cases. Understanding vertical integration as a strategy — and the conditions under which it becomes predatory — is essential for reading both the healthcare and tech sections of the KB. ## See Also - [[Healthcare Industry Ecosystem]] — the system-level map - [[UnitedHealth Group]] — the paradigm case - [[Pharmacy Benefit Managers]] — the most contested link in the chain - [[Hospital Consolidation]] — the horizontal counterpart in healthcare - [[Drug Pricing]] · [[Prior Authorization]] · [[Claim Denial]] — the patient-impact nodes - [[Antitrust]] · [[Sherman Antitrust Act]] — the legal framework - [[Lina Khan]] · [[FTC]] — the enforcement actors - [[Regulatory Capture]] — what happens when the regulated firms write the rules - [[Managed Care]] — the insurance model that vertical integration extends - [[CVS Health]] · [[Cigna]] · [[Humana]] · [[Centene]] — the other major players - [[Kaiser Permanente]] — the nonprofit vertical-integration model